TVM CAPITAL

TVM Capital is a global venture and growth capital firm that aims to finance select biopharmaceutical and medical device companies. TVM Capital was founded in 1983 and is based Munich, Bavaria.
TVM CAPITAL
Social Links:
Industry:
Health Care Medical Venture Capital
Founded:
1983-01-01
Status:
Active
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Apple Mobile Web Clips Icon WordPress Nginx Sitelinks Search Box Yoast WordPress SEO Plugin Yoast SEO Premium Yoast Plugins Starfield Technologies
Similar Organizations
Apollo Health Ventures
Apollo Health Ventures is a venture capital firm investing in seed and early stage biotechnology companies.
Context Therapeutics
Context Therapeutics is a clinical-stage biopharmaceutical company.
Section 32
Section 32 is a venture capital fund that invests at the cutting edge of technology, healthcare, and life sciences.
Current Advisors List
Current Employees Featured
Founder
Investments List
Date | Company | Article | Money raised |
---|---|---|---|
2015-04-29 | Rapid Micro Biosystems | TVM Capital investment in Series C - Rapid Micro Biosystems | 25 M USD |
2014-06-23 | Definiens | TVM Capital investment in Venture Round - Definiens | 15 M EUR |
2014-05-16 | Proteon Therapeutics | TVM Capital investment in Series D - Proteon Therapeutics | 45 M USD |
2014-04-04 | Rapid Micro Biosystems | TVM Capital investment in Venture Round - Rapid Micro Biosystems | 6 M USD |
2014-03-20 | invendo medical | TVM Capital investment in Venture Round - invendo medical | 28 M USD |
2013-11-20 | Argos Therapeutics | TVM Capital investment in Series E - Argos Therapeutics | 17.5 M USD |
2013-10-23 | F-Star Therapeutics | TVM Capital investment in Series A - F-Star Therapeutics | 9.4 M USD |
2013-06-26 | Rapid Micro Biosystems | TVM Capital investment in Series B - Rapid Micro Biosystems | 32.6 M USD |
2012-10-01 | Definiens | TVM Capital investment in Venture Round - Definiens | 10 M EUR |
2012-07-25 | Bluebird Bio | TVM Capital investment in Series D - Bluebird Bio | 60 M USD |